MTPH.L Stock - Midatech Pharma plc
Unlock GoAI Insights for MTPH.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | $381,000 | $699,000 | $578,000 | $343,000 |
| Gross Profit | $-5,437,000 | $-3,686,000 | $-4,412,000 | $-4,076,000 | $-5,725,000 |
| Gross Margin | N/A | -967.5% | -631.2% | -705.2% | -1669.1% |
| Operating Income | $-9,199,000 | $-8,014,000 | $-8,932,000 | $-6,998,000 | $-10,671,000 |
| Net Income | $-5,729,000 | $-7,079,000 | $-7,656,000 | $-5,460,000 | $-22,189,000 |
| Net Margin | N/A | -1858.0% | -1095.3% | -944.6% | -6469.1% |
| EPS | $-11.57 | $-2.29 | $-49.43 | $-35.25 | $-143.27 |
Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Visit WebsiteEarnings History & Surprises
MTPH.LEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2023 | Sep 12, 2023 | — | — | — | — |
Q2 2023 | Apr 24, 2023 | — | — | — | — |
Q4 2018 | Dec 31, 2018 | — | $-16.71 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-30.84 | — | — |
Q4 2016 | Dec 31, 2016 | — | $-55.07 | — | — |
Latest News
Frequently Asked Questions about MTPH.L
What is MTPH.L's current stock price?
What is the analyst price target for MTPH.L?
What sector is Midatech Pharma plc in?
What is MTPH.L's market cap?
Does MTPH.L pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to MTPH.L for comparison